FDA to the public: We will be nimble in response to omicron

The Food and Drug Administration assured the public Tuesday it is “actively working” with drugmakers and global partners to understand whether the omicron variant of the coronavirus can puncture existing defenses and if updated products are needed.

Read more…

Please follow and like us: